Lausanne (SUI), 3 February 2017 – The FEI has announced seven adverse analytical findings involving prohibited substances in UAE Endurance events. The horses were tested at four different events at the Al Wathba venue in Abu Dhabi.
All seven horses have tested positive to the same four prohibited substances, the stimulant Caffeine and its metabolites Theophylline, Theobromine and Paraxanthine. Equally, Theophylline, used for the treatment of asthma and various respiratory diseases, can be metabolised to Caffeine. One of the horses also tested positive to the corticosteroid Flumetasone, which is used in the treatment of skin disorders.
Theophylline, Caffeine and Theobromine are listed as Controlled Medication and Specified Substances under the FEI’s Equine Anti-Doping and Controlled Medication Rules (EADCMRs). Paraxanthine is a Banned Substance under the FEI EADCMRs.
Samples taken at the CEI2* 120-kilometre ladies ride at Al Wathba, Abu Dhabi (UAE) on 26 November 2016 from the horse Rafik de Kerpoint (FEI ID 103ZQ05/UAE), ridden by Amy Louise McAuley (FEI ID 10066318/IRL) tested positive for all four substances.
The horses Castlebar Lightning (FEI ID UAE41150/UAE), ridden by Saeed Sultan Shames Al Maamri (FEI ID 10048603/UAE), Intisaar (FEI ID ESP40786/UAE), ridden by Sheikh Rashid Dalmook Al Maktoum (FEI ID 10034071/UAE) and Mraseel (FEI ID 104ED73/UAE), ridden by Sheikh Sh Hamed Dalmook Al Maktoum (FEI ID 10073722/UAE) in the CEI2* 120-kilometre ride at Al Wathba on 17 December 2016, tested positive for the four substances. The horse Mraseel also tested positive for Flumetasone.
The horse Salam Banquetol (FEI ID 103YG68/UAE), ridden by Abdulla Ghanim Al Marri (FEI ID 10054553/UAE) to finish second at the CEI2* 120 kilometre event at Al Wathba on 24 December, tested positive to all four substances, as did both Tom Jones TE (FEI ID 104ER04), ridden by Abdulla Ghanim Al Marri (FEI ID 10054553/UAE), and Aspenview Amir (FEI ID 104OZ13), ridden by Saeed Ahmad Jaber Al Harbi (FEI ID 10084918/UAE) at the CEI2* 120-kilometre event at Al Wathba on 14 January 2016.
The seven athletes and the trainers Ismail Mohd, Khalifa Ghanim Al Marri and Mohd Ahmed Ali Al Subose have all been provisionally suspended from the date of notification (30 January 2017). The seven horses are also suspended for a two-month period from the date of notification.
“We take all breaches of the FEI anti-doping regulations extremely seriously and these latest positives demonstrate clearly that those using prohibited substances will be caught,” FEI Secretary General Sabrina Ibáñez said.
“This is the first time that we have suspended the trainers at the same time as the athletes, but when there are multiple breaches by one trainer, it is clear that there is something wrong with the stable management. Suspending the trainers immediately, rather than waiting until the athlete has been prosecuted, confirms that the FEI will not tolerate any attempts to enhance the performance of the horse.”
The FEI’s Prohibited Substances List is divided into two sections – Controlled Medication and Banned Substances. Controlled Medication substances are those that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition. Banned (doping) substances should never be found in the body of the horse.
The FEI has also introduced the concept of Specified Substances. Specified Substances should not in any way be considered less important or less dangerous than other Prohibited Substances. Rather, they are simply substances which are more likely to have been ingested by Horses for a purpose other than the enhancement of sport performance, for example, through a contaminated food substance.
In the case of an adverse analytical finding for a Banned Substance, the Person Responsible (PR) is automatically provisionally suspended from the date of notification. The horse is suspended for two months. In the case of a positive for a specified substance, provisional suspension is not automatic.
FEI Media Contacts:
Director Press Relations
+41 787 506 142
Manager Press Relations
Tel: +41 787 506 145